Petal Pharma Private Ltd
About Petal Pharma Private Ltd
Data last updated:
Petal Pharma Private Ltd is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 February 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1986PTC023492. Its GSTIN is 09AAACP7825R1ZN (Uttar Pradesh).
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors including Greesh Kumar Juneja and Anita Juneja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G 54 Vikash Marglaxmi Nagar, Delhi, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.22 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net profit of ₹87,833 (net margin 39.5%) and EBITDA of ₹1.19 Lakh (EBITDA margin 53.4%). Revenue has declined at a compounded annual rate (CAGR) of 58% over three years and 41% over five years.
As per MCA filings, the company has satisfied charges of ₹30.92 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressG 54 Vikash Marglaxmi Nagar, Delhi, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Petal Pharma Private Ltd
FY 2025 filings availablePetal Pharma Private Ltd reported revenue of ₹2.22 Lakh (down 98% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 41% over five years, including a 98% fall in the latest year. EBITDA fell 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹1.19 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹87,833 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 53.4% | |
| Net Profit Margin | 39.5% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2019-20 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Petal Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Petal Pharma Private Ltd
Petal Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Greesh Kumar Juneja Also directs: Quality Bestochem Formulations Private Limited, Salute Bestochem Private Limited, Bigbrother Nutra Care Private Limited and 5 more | Director | 11 Apr 2018 | 8 Years 6 Months | Current |
| Anita Juneja Also directs: Bestochem Formulations (India) Limited, G. A. Davai India Private Limited, Newday Nutra Health Private Limited and 1 more | Director | 01 Dec 1991 | 34 Years 10 Months | Current |
| Urmila Prakash | Director | 01 Dec 1991 | 34 Years 10 Months | Current |
| Vijay Prakash Also directs: Quality Bestochem Formulations Private Limited, Salute Bestochem Private Limited, Bigbrother Nutra Care Private Limited and 3 more | Director | 11 Apr 2018 | 8 Years 6 Months | Current |
Auditor Details
Petal Pharma Private Ltd is audited by SANJAY PARWANDA & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANJAY PARWANDA & CO | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jun 2016 | Hdfc Bank Limited | ₹16.17 Cr | Satisfied |
| 15 Mar 2007 | Allahabad Bank | ₹14.75 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases
Petal Pharma Private Ltd has 2 court cases on record: 1 filed by Petal Pharma, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0419-Indirect Taxes Matters : Interpretation of the Central Excise Act & the rules) | Filed by the company against an individual | Disposed |
| High Court, UTTARPRADESH | Tax appeal | Filed against the company by Commissioner of Coustoms Central Excise and Service Tax | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Petal Pharma.
: available in the company report
Recent Activity
Petal Pharma Private Ltd has 4 board changes on record since 1991: 4 appointments. The latest: Greesh Kumar Juneja was appointed as Director on 11 Apr 2018.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Petal Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACP7825R1ZN | Uttar Pradesh | Active | 27 Apr 2018 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Petal Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 February 1986 (40+ years old) and is registered under CIN U74899DL1986PTC023492.
Petal Pharma has 4 current directors:
- Greesh Kumar Juneja - Director
- Anita Juneja - Director
- Urmila Prakash - Director
- Vijay Prakash - Director
The latest financial statements of Petal Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Petal Pharma is 09AAACP7825R1ZN, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Petal Pharma is U74899DL1986PTC023492. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Petal Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the high courts.
Petal Pharma was incorporated on 28 February 1986, making it 40+ years old. It is registered with the Registrar of Companies, Delhi.
Greesh Kumar Juneja was appointed as Director on 11 Apr 2018. Vijay Prakash was appointed as Director on 11 Apr 2018. Anita Juneja was appointed as Director on 01 Dec 1991. Petal Pharma has 4 board changes on record in total.
The registered office of Petal Pharma is at G 54 Vikash Marglaxmi Nagar, Delhi, India.
Petal Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.